首页> 外文期刊>Archives of disease in childhood >P47?Extent of paediatric exposure to pharmaceutical excipients: an exploratory study
【24h】

P47?Extent of paediatric exposure to pharmaceutical excipients: an exploratory study

机译:P47?药物赋形剂的儿科暴露程度:探索性研究

获取原文
       

摘要

Aim The assumption that excipients are inactive therefore non-harmful to patients is a declining opinion due to raised safety concerns of excipient activity, particularly in children. 1 There is limited data on the safety of excipients in children and a lack of standardisation of the risk-benefit use of excipients in the different paediatric populations. 2 This study aimed to investigate the extent of excipient exposure in children taking long-term oral liquids, admitted to Hospital, and to identify whether patients could be switched to a solid alternative due to the harm posed from liquid formulations. Method A prospective observational study conducted in a UK paediatric hospital. The electronic medication chart for hospitalised children aged 0–18 years on long-term (for ≥6 weeks) oral liquid medicines, were reviewed over a four-week period. A priority list of eight excipients (called harmful excipients) with known reported hazards was developed based on literature: propylene glycol, ethanol, parabens, benzyl alcohol, aspartame, sorbitol, polysorbate 80 and benzoic acid. The list was used to determine the extent of children exposure to the harmful excipients. Considering patient factors (age, swallowing ability, treated condition), prescribed dose and availability of solid dosage forms, the included long-term liquid medicines were assessed for a potential solid form alternative by a specialist paediatric clinical pharmacist. Results A total of 302 oral liquid medicine formulations prescribed for 60 patients (age range 10 days – 17 years) were included in the study, of which 68.9% (208/302) were long-term oral liquid formulations. The 208 oral liquid formulation contained a total of 1044 excipients resulted in 17.4 (± 9) excipients per patients. Majority of patients (98.3%, 59/60) were exposed to at least one harmful excipient in their medicines. Children aged 2–11 years and 6–11 years were exposed the most to harmful excipients (mean 8.2 ± 4.9 exposure per patient). Parabens (81.7%, 49/60) was the most common harmful excipient patients were exposed to, followed by sorbitol (76.7%, 46/60), ethanol (75.0%, 45/60) and propylene glycol (70.0%, 42/60). Considering patient factors, prescribed dose and availability of solid formulations, it was found that almost third of the prescribed long-term oral liquid medicines (33.0%, 68/208) could be switched to tablet or capsule forms by pharmacist without any change to the prescribed dose. While for another 3.4% (7/208) long-term liquid medicines could be switched to solid dosage forms with prescriber approval, as prescribed doses would need to be adjusted slightly. Conclusion The study highlights the extent of excipients exposure in children on long-term oral liquid medicines, many of which could potentially be harmful. Healthcare professionals should aim to reduce the long-term risks of excipients by providing an oral solid substitute to replace oral liquid formulation, where possible, and ensuring excipients are within safe, acceptable limits.
机译:旨在假设赋形剂不活跃,因此对患者无危害是由于提高赋形剂活动的安全问题,特别是在儿童中,这是一个下降的意见。 1有关儿童赋形剂安全的数据有限,缺乏不同儿科人群中赋形剂的风险效益使用的标准化。 2本研究旨在探讨服用长期口服液体的儿童赋形剂暴露程度,并识别患者是否可以通过液体制剂造成的损害而转换为固体替代品。方法在英国儿科医院进行预期观察研究。长期(≥6周)口服液体药物0-18岁的住院儿童的电子药物图表在4周内进行审查。基于文献:丙二醇,乙醇,羟基甲醚,苄醇,阿斯巴甜,山梨糖醇,聚山梨醇酯80和苯甲酸开发了具有已知报告的危害的八种赋形剂(称为有害赋形剂)列表。该列表用于确定儿童的程度暴露于有害赋形剂。考虑到患者因素(年龄,吞咽能力,治疗状况),规定剂量和固体剂型的可用性,所包含的长期液体药物被专科小儿临床药剂师替代的潜在的固体形式评估。结果研究总共包括60例患者的302种口服液体药物制剂(10天 - 17岁),其中68.9%(208/302)是长期口服液体制剂。 208个口服液体制剂总共1044例赋形剂,导致每位患者的17.4(±9)赋形剂。大多数患者(98.3%,59/60)暴露于药物中至少一个有害赋形剂。 2-11岁和6-11岁的儿童暴露于有害赋形剂最多(平均每位患者8.2±4.9暴露)。羟基苯甲酸酯(81.7%,49/60)是最常见的有害赋形剂患者暴露于山梨糖醇(76.7%,46/60),乙醇(75.0%,45/60)和丙二醇(70.0%,42 / 60)。考虑到患者因素,规定剂量和固体制剂的可用性,发现该规定的长期口服液体药物(33.0%,68/208)中的近三分可以通过药剂师切换到片剂或胶囊形式,而没有任何变化规定剂量。虽然另外3.4%(7/208)长期液体药物可以用戊纤维批准切换到固体剂型,因为需要稍微调整规定剂量。结论该研究突出了儿童长期口服液体药物赋形剂暴露的程度,其中许多可能是有害的。医疗保健专业人员旨在通过提供口腔固体替代品来减少赋形剂的长期风险,以在可能的情况下替代口服液体制剂,并确保赋形剂在安全,可接受的限制中。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号